Effect of Hypnosis in the Management of Anxiety and Chemo-induced Symptoms in Adolescents and Young Adults With Sarcoma or Germ Cell Tumor and in Young Women With Breast Cancer

NCT ID
NCT07614620
Registry status
Recruiting
Study type
Interventional
Phase
Not applicable
Sponsor
Institut Bergonié
Conditions
Breast Cancer, Germ Cell Tumor of Testis, Ovarian Tumor, Sarcoma

Overview

ClinicalTrials.gov lists this study as Recruiting.

Official title: Effect of Hypnosis in the Management of Anxiety and Chemo-induced Symptoms in Adolescents and Young Adults With Sarcoma or Germ Cell Tumor and in Young Women With Breast Cancer.

Enrollment: 70 participants (Estimated).

What is being studied

  • Intervention: Behavioral Disciplines and Activities
  • Intervention: Complementary Therapies
  • Intervention: Hypnosis
  • Other: HYPNOSIS
  • Intervention: Mind-Body Therapies
  • Intervention: Psychotherapy
  • Intervention: Therapeutics

Who may be eligible

Ages
15 Years to 49 Years
Sex
All
Healthy volunteers accepted
No

ClinicalTrials.gov lists the following eligibility criteria.

Inclusion Criteria: 1. Newly diagnosed patients receiving initial care and follow-up at the Institut Bergonié during treatment: 1. Adolescents or young adults (AJA) aged 15 to 39 with soft tissue or bone sarcoma or a germ cell tumor (testicular, ovarian), 2. Young women aged 15 to 49 with breast cancer. 2. Treatment with neoadjuvant chemotherapy based on anthracyclines and/or alkylating agents. 3. Treatment administered as: 1. Inpatient for patients with soft tissue or bone sarcoma or a germ cell tumor (testicular, ovarian), 2. Outpatient or day hospital for female patients with breast cancer. 4. Dated and signed informed consent (if the patient is a minor, consent must also be signed by the legal guardians). 5. Patient enrolled in a social security program in accordance with current regulations. Exclusion Criteria: 1. Known contraindications to hypnosis (psychotic disorders, mental disorders, confusion, deafness, severe cognitive impairment, etc.) 2. Patients who have already undergone hypnosis sessions within 6 months prior to enrollment. 3. Geographic, social, or psychological factors rendering the patient unable to comply with the study's follow-up and procedures. 4. Patients who are deprived of their liberty or subject to a legal protection measure (guardianship, conservatorship, judicial protection, or family authorization).

Study locations

1 study location is listed.

Recruiting site status is explicitly provided for 1 location; 1 is listed as Recruiting.

Countries: France

Sample of listed locations

  • Institut Bergonie — Bordeaux, 33600, France — Recruiting

Study details

Start date
September 15, 2026
Primary completion date
June 30, 2028
Completion date
December 1, 2028
First posted
May 29, 2026

Source and update information

Source
ClinicalTrials.gov
NCT ID
NCT07614620
Registry last updated
September 22, 2026
QualifiedStudies registry data refreshed
September 28, 2026
QualifiedStudies record fetched
September 28, 2026

View NCT07614620 on ClinicalTrials.gov

Trial information can change. Confirm current study details with the study team or the registry.

About joining clinical research

Find clinical trials you may match with

QualifiedStudies can help you search for research opportunities related to your health. Availability of this specific study through QualifiedStudies has not been established.

Find clinical trials you may match with | Clinical trial FAQ